8ONG | pdb_00008ong

Structure of the endothelial monocyte activating polypeptide II (EMAP II) in solution


Experimental Data Snapshot

  • Method: SOLUTION NMR
  • Conformers Calculated: 200 
  • Conformers Submitted: 19 
  • Selection Criteria: structures with the lowest energy 

  • Method: SOLUTION SCATTERING

wwPDB Validation 3D Report Full Report

Validation slider image for 8ONG

This is version 1.1 of the entry. See complete history

Literature

Solution 3D structure and conformational flexibility of the endothelial monocyte activating polypeptide II (EMAP II) revealed by NMR spectroscopy and molecular dynamics simulations.

Lozhko, D.Kolomiiets, L.Zhukova, L.Taube, M.Kozak, M.Dadlez, M.Kornelyuk, O.Zhukov, I.

(2026) J Struct Biol 218: 108280-108280

  • DOI: https://doi.org/10.1016/j.jsb.2025.108280
  • Primary Citation Related Structures: 
    8ONG

  • PubMed Abstract: 

    Endothelial monocyte activating polypeptide II (EMAP II) is the C-terminal domain of its precursor, AIMP1/p43 polypeptide, a multifunctional protein with diverse functional cytokine activities and tRNA-binding abilities. Several X-ray crystallographic structures of EMAP II are available in the PDB database. However, its NMR-based structure, presented in this work indicates partition of its structure into two domains characterized by substantial differences in structural dynamics. Based on 15 N relaxation experiments, hydrogen-deuterium exchange (HDX) data and molecular dynamics simulations we conclude that observed differences in dynamics may enable dual mechanisms of tRNA binding and cytokine function of EMAP II. Although in general in-solution EMAP II structure studied here is highly similar to its in-crystal X-ray structure, the N-terminal segment responsible for cytokine activity exhibited reduced deuterium exchange rate and demonstrated higher accessibility to the solvent compared to X-ray structures and the AlphaFold2 model. Such differences may be important for understanding cytokine function of EMAP II. The tRNA-binding motif characterized by different orientation of the side chain of tryptophan 128, which can play a significant role in the regulation of tRNA binding.


  • Organizational Affiliation
    • Institute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine, 150 Zabolotnogo str., Kyiv 03-143, Ukraine.

Macromolecule Content 

  • Total Structure Weight: 18.56 kDa 
  • Atom Count: 1,293 
  • Modeled Residue Count: 169 
  • Deposited Residue Count: 169 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Aminoacyl tRNA synthase complex-interacting multifunctional protein 1169Homo sapiensMutation(s): 0 
Gene Names: AIMP1EMAP2SCYE1
UniProt & NIH Common Fund Data Resources
Find proteins for Q12904 (Homo sapiens)
Explore Q12904 
Go to UniProtKB:  Q12904
PHAROS:  Q12904
GTEx:  ENSG00000164022 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ12904
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: SOLUTION NMR
  • Conformers Calculated: 200 
  • Conformers Submitted: 19 
  • Selection Criteria: structures with the lowest energy 
  • Method: SOLUTION SCATTERING

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Polish National Science CentrePolandN 30107131/2150
European Communitys Seventh Framework ProgrammeEuropean UnionBioNMR contract 261863

Revision History  (Full details and data files)

  • Version 1.0: 2024-04-10
    Type: Initial release
  • Version 1.1: 2026-08-05
    Changes: Database references, Structure summary